Pay Rs 900 for extra cabin baggage on Jet Airways

Mangaluru, Feb 23: Karnataka Minister for Fisheries and Religious Endowment Kota Shrinivas Poojari on Sunday said that there will be no shortage of water during the summer season in Dakshina Kannada district as per a review done by the district administration and the Panchayati Raj Department.

He said that periodic review will be conducted and based on that appropriate decisions will be taken.

Speaking to reporters on Sunday, February 23, Poojari said that the main source of water for Mangaluru, the Thumbe vented dam, has a steady inflow of water.

Davanagere, Jan 16: Congress leader D K Shivakumar on Thursday turned down all the recent media reports of him aspiring for the coveted Karnataka Pradesh Congress Committe (KPCC) president post.

Terming all the news, doing rounds, as baseless, Shivakumar said that he never made any attempt to become KPCC president. "All I want to do is work for my people and party", he asserted.

Referring to Chief Minister B S Yediyurappa's visit to Harihar's 'Our Lady of Health Minor Basilica' programme, Shivakumar said."I'm not concerned about what others are doing, everyone is free to take part in the programmes."

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.